Seer, Inc. $SEER
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Laboratory Analytical Instruments
- Headquarters
- Redwood City, CA
- Fiscal year end
- December 31
- Shares outstanding
- 55,372,015 [10-Q 2026-08-11]
What the company doesAI summary of filing
Seer, Inc. develops and sells the Proteograph Product Suite, an integrated platform for deep, unbiased proteomic analysis used by researchers in academic institutions, biopharmaceutical companies, biobanks, and clinical research organizations across more than 20 countries. The company generates revenue from the sale of consumable assays, automation instruments, and data analysis software. Since its commercial launch in 2021, Seer has served more than 190 customers and is in the revenue-generating stage, with recent product launches including the Proteograph ONE assay and SP200 automation instrument in May 2025 that enable processing of over 1,000 samples per week. [10-K 2026-03-02]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $5.89M | −$33.74M | −$25.01M | $26.07M | [10-Q 2026-08-11] |
| FY ended Dec 2025 | $16.58M | −$73.60M | −$44.45M | $47.28M | [10-K 2026-03-02] |
| FY ended Dec 2024 | $14.17M | −$86.60M | −$46.11M | $40.75M | [10-K 2026-03-02] |
- Quarterly cash burn
- −$12.50M
- Cash runway Estimate
- ~6.3 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2026-02-23 | 56,420,772 | [10-K/A 2026-04-30] |
| 2026-05-08 | 54,981,551 | [10-Q 2026-05-13] |
| 2026-08-05 | 55,372,015 | [10-Q 2026-08-11] |
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-07-08. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2025-07-08 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-08] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-18 | Horn David R. | sell | 7,309 | $2.03 | [4 2026-08-19] |
| 2026-07-28 | Roelofs Nicolas H Phd | grant | 16,500 | — | [4 2026-07-30] |
| 2026-07-28 | Ro Isaac | grant | 12,375 | — | [4 2026-07-30] |
| 2026-07-28 | Nishar Dipchand | grant | 16,500 | — | [4 2026-07-30] |
| 2026-07-28 | Mcguire Terrance | grant | 16,500 | — | [4 2026-07-30] |
| 2026-07-28 | Langer Robert | grant | 16,500 | — | [4 2026-07-30] |
| 2026-07-28 | Gulyani Meeta | grant | 16,500 | — | [4 2026-07-30] |
| 2026-07-08 | Nishar Dipchand | sell | 10,660 | $2.18 | [4 2026-07-10] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-18 | 8-K | Director or officer change |
| 2026-08-11 | 10-Q | Quarterly report |
| 2026-08-11 | 8-K | Results of operations |
| 2026-07-31 | 8-K | Shareholder vote results |
| 2026-07-31 | 8-K | Other events |
| 2026-07-20 | 8-K | Other events |
| 2026-07-02 | 8-K | Other events |
| 2026-05-22 | 8-K | Other events |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Results of operations |
| 2026-05-04 | 8-K | Other events |
Alerts for $SEER
Email me when Seer, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.